Ayala Pharmaceuticals Reports Financial Results For the Fiscal Year Ended October 31, 2022
10.02.2023 - REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) - Ayala Pharmaceuticals, Inc. (f/k/a Advaxis Inc.) (the “Company,” “New Ayala,” “we,” “us” or “our”) (OTCQX: ADXS), a clinical-stage oncology company, today announces ...
Source: wallstreet-online.de